New strategies for the precision treatment of HER2-driven tumours

M Hofmann, O Stoss, D Shi, R Büttner, M van de Vijver, W Kim, A Ochiai, J Rüschoff, T Henkel, Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology. ,vol. 52, pp. 797- 805 ,(2008) , 10.1111/J.1365-2559.2008.03028.X

Edith A Perez, Edward H Romond, Vera J Suman, Jong-Hyeon Jeong, George Sledge, Charles E Geyer Jr, Silvana Martino, Priya Rastogi, Julie Gralow, Sandra M Swain, Eric P Winer, Gerardo Colon-Otero, Nancy E Davidson, Eleftherios Mamounas, Jo Anne Zujewski, Norman Wolmark, None, Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831 Journal of Clinical Oncology. ,vol. 32, pp. 3744- 3752 ,(2014) , 10.1200/JCO.2014.55.5730

Jeffrey L Nordstrom, Sergey Gorlatov, Wenjun Zhang, Yinhua Yang, Ling Huang, Steve Burke, Hua Li, Valentina Ciccarone, Tengfei Zhang, Jeffrey Stavenhagen, Scott Koenig, Stanford J Stewart, Paul A Moore, Syd Johnson, Ezio Bonvini, Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties Breast Cancer Research. ,vol. 13, pp. 1- 14 ,(2011) , 10.1186/BCR3069

Sara M. Tolaney, William T. Barry, Chau T. Dang, Denise A. Yardley, Beverly Moy, P. Kelly Marcom, Kathy S. Albain, Hope S. Rugo, Matthew Ellis, Iuliana Shapira, Antonio C. Wolff, Lisa A. Carey, Beth A. Overmoyer, Ann H. Partridge, Hao Guo, Clifford A. Hudis, Ian E. Krop, Harold J. Burstein, Eric P. Winer, Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer The New England Journal of Medicine. ,vol. 372, pp. 134- 141 ,(2015) , 10.1056/NEJMOA1406281

Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park Peter J. 12 Kucherlapati Raju 13, Genome data analysis: Baylor College of Medicine Creighton Chad J. 22 23 Donehower Lawrence A. 22 23 24 25, Institute for Systems Biology Reynolds Sheila 31 Kreisberg Richard B. 31 Bernard Brady 31 Bressler Ryan 31 Erkkila Timo 32 Lin Jake 31 Thorsson Vesteinn 31 Zhang Wei 33 Shmulevich Ilya 31, Oregon Health & Science University Anur Pavana 37 Spellman Paul T. 37, NCI Yan Chunhua 44 Hu Ying 44 Meerzaman Daoud 44, Tissue source sites: ABS-IUPUI Tarvin Katie 48 Saller Charles 49 Sandusky George 50 Mitchell Colleen 50, Christiana Iacocca Mary V. 51 Brown Jennifer 51 Rabeno Brenda 51 Czerwinski Christine 51 Petrelli Nicholas 51, Cureline Dolzhansky Oleg 52 Abramov Mikhail 53 Voronina Olga 54 Potapova Olga 54, Duke University Medical Center Marks Jeffrey R. 55, ILSBio Van Le Xuan 58 Kohl Bernard 58 Viet Tien Nguyen 59 Thorp Richard 60 Van Bang Nguyen 61 Sussman Howard 62 Duc Phu Bui 61 Hajek Richard 63 Phi Hung Nguyen 64 Viet The Phuong Tran 65 Quyet Thang Huynh 66 Zaki Khan Khurram 60, International Genomics Consortium Penny Robert 67 Mallery David 67 Curley Erin 67 Shelton Candace 67 Yena Peggy 67, Mayo Clinic Ingle James N. 68 Couch Fergus J. 68 Lingle Wilma L. 68, MSKCC King Tari A. 69, MD Anderson Cancer Center Maria Gonzalez-Angulo Ana 38 70 Mills Gordon B. 70 Dyer Mary D. 70 Liu Shuying 70 Meng Xiaolong 70 Patangan Modesto 70, University of California San Francisco Waldman Frederic 71 92 72 93 Stöppler Hubert 73, University of North Carolina Kimryn Rathmell W. 15 Thorne Leigh 15 74 Huang Mei 15 74 Boice Lori 15 74 Hill Ashley 15, Roswell Park Cancer Institute Morrison Carl 75 Gaudioso Carmelo 75 Bshara Wiam 75, University of Miami Daily Kelly 76 Egea Sophie C. 76 Pegram Mark D. 76 Gomez-Fernandez Carmen 76, University of Pittsburgh Dhir Rajiv 77 Bhargava Rohit 78 Brufsky Adam 78, Walter Reed National Military Medical Center Shriver Craig D. 79 Hooke Jeffrey A. 79 Leigh Campbell Jamie 79 Mural Richard J. 80 Hu Hai 80 Somiari Stella 80 Larson Caroline 80 Deyarmin Brenda 80 Kvecher Leonid 80 Kovatich Albert J. 81, Project team: National Cancer Institute Sheth Margi 88 Demchok John A. 88 Mills Shaw Kenna R. 88 Yang Liming 88 Eley Greg 89 Ferguson Martin L. 90 Tarnuzzer Roy W. 88 Zhang Jiashan 88 Dillon Laura AL 88 Buetow Kenneth 44 Fielding Peter 88, National Human Genome Research Institute Ozenberger Bradley A. 91 Guyer Mark S. 91 Sofia Heidi J. 91 Palchik Jacqueline D. 91, None, Comprehensive molecular portraits of human breast tumours Nature. ,vol. 490, pp. 61- 70 ,(2012) , 10.1038/NATURE11412

Dennis Slamon, Wolfgang Eiermann, Nicholas Robert, Tadeusz Pienkowski, Miguel Martin, Michael Press, John Mackey, John Glaspy, Arlene Chan, Marek Pawlicki, Tamas Pinter, Vicente Valero, Mei-Ching Liu, Guido Sauter, Gunter von Minckwitz, Frances Visco, Valerie Bee, Marc Buyse, Belguendouz Bendahmane, Isabelle Tabah-Fisch, Mary-Ann Lindsay, Alessandro Riva, John Crown, None, Adjuvant Trastuzumab in HER2-Positive Breast Cancer The New England Journal of Medicine. ,vol. 365, pp. 1273- 1283 ,(2011) , 10.1056/NEJMOA0910383

Xavier Pivot, Gilles Romieu, Marc Debled, Jean-Yves Pierga, Pierre Kerbrat, Thomas Bachelot, Alain Lortholary, Marc Espié, Pierre Fumoleau, Daniel Serin, Jean-Philippe Jacquin, Christelle Jouannaud, Maria Rios, Sophie Abadie-Lacourtoisie, Nicole Tubiana-Mathieu, Laurent Cany, Stéphanie Catala, David Khayat, Iris Pauporté, Andrew Kramar, None, 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial Lancet Oncology. ,vol. 14, pp. 741- 748 ,(2013) , 10.1016/S1470-2045(13)70225-0

Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John MS Bartlett, Michael Bilous, Patrick Fitzgibbons, Wedad Hanna, Robert B Jenkins, Pamela B Mangu, Soonmyung Paik, Edith A Perez, Michael F Press, Patricia A Spears, Gail H Vance, Giuseppe Viale, Daniel F Hayes, None, Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update Journal of Clinical Oncology. ,vol. 31, pp. 3997- 4013 ,(2013) , 10.1200/JCO.2013.50.9984

Fabrice André, Ruth O'Regan, Mustafa Ozguroglu, Masakazu Toi, Binghe Xu, Guy Jerusalem, Norikazu Masuda, Sharon Wilks, Francis Arena, Claudine Isaacs, Yoon-Sim Yap, Zsuzsanna Papai, Istvan Lang, Anne Armstrong, Guillermo Lerzo, Michelle White, Kunwei Shen, Jennifer Litton, David Chen, Yufen Zhang, Shyanne Ali, Tetiana Taran, Luca Gianni, Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial Lancet Oncology. ,vol. 15, pp. 580- 591 ,(2014) , 10.1016/S1470-2045(14)70138-X

Deborah Lindquist, Stephen Chan, C. Gilles Romieu, Tadeusz Pienkowski, Agnieszka Jagiello-Gruszfeld, John Crown, Arlene Chan, Bella Kaufman, Dimosthenis Skarlos, Mario Campone, Neville Davidson, Mark Berger, Cristina Oliva, Stephen D. Rubin, Steven Stein, David Cameron, Charles E. Geyer, John Forster, Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer The New England Journal of Medicine. ,vol. 355, pp. 2733- 2743 ,(2006) , 10.1056/NEJMOA064320